ERIKSSON, Mikael, Magdalena RYCHLOWSKA-PRUSZYŇSKA, Monica CSOKA, Edita KABÍČKOVÁ, Peter MÚDRY, Pia LISJÖ and Karin GANLÖV. Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study. In 38th Meeting of the Scandinavian Sarcoma Group. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study
Authors ERIKSSON, Mikael (752 Sweden), Magdalena RYCHLOWSKA-PRUSZYŇSKA (616 Poland), Monica CSOKA (348 Hungary), Edita KABÍČKOVÁ (203 Czech Republic), Peter MÚDRY (203 Czech Republic, guarantor, belonging to the institution), Pia LISJÖ (752 Sweden) and Karin GANLÖV (752 Sweden).
Edition 38th Meeting of the Scandinavian Sarcoma Group, 2017.
Other information
Original language English
Type of outcome Presentations at conferences
Field of Study 30200 3.2 Clinical medicine
Country of publisher Denmark
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/17:00098889
Organization unit Faculty of Medicine
Keywords in English high-dose methotrexate
Tags EL OK
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 16/3/2018 15:26.
Abstract
Poster Development of a new promising rescue agent for high-dose methotrexate (HDMTX) treatment in osteosarcoma - a safety and dose-finding study.
PrintDisplayed: 27/4/2024 02:16